The global Androgen Antagonist market was valued at 6887 million in 2024 and is projected to reach US$ 10300 million by 2032, at a CAGR of 6.1% during the forecast period.
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Steroidal Androgen Antagonist segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Androgen Antagonist include Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Androgen Antagonist companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Androgen Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgen Antagonist. This report contains market size and forecasts of Androgen Antagonist in global, including the following market information:
Global Androgen Antagonist market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Androgen Antagonist companies in 2024 (%)
Total Market by Segment:
Global Androgen Antagonist market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Androgen Antagonist market segment percentages, by Type, 2024 (%)
Steroidal Androgen Antagonist
Nonsteroidal Androgen Antagonist
Global Androgen Antagonist market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Androgen Antagonist market segment percentages, by Application, 2024 (%)
Prostate Cancer
Benign Prostatic Hyperplasia
Polycystic Ovary Syndrome (POCS)
Others
Global Androgen Antagonist market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Androgen Antagonist market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Androgen Antagonist revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Androgen Antagonist revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Merck
Sanofi
Orion Corporation
Hengrui
Bayer
Schering-Plough
Hinova Pharma
Jiangsu Hengrui Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Androgen Antagonist, market overview.
Chapter 2: Global Androgen Antagonist market size in revenue.
Chapter 3: Detailed analysis of Androgen Antagonist company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Androgen Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Androgen Antagonist Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Androgen Antagonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Androgen Antagonist Overall Market Size
2.1 Global Androgen Antagonist Market Size: 2024 VS 2032
2.2 Global Androgen Antagonist Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Androgen Antagonist Players in Global Market
3.2 Top Global Androgen Antagonist Companies Ranked by Revenue
3.3 Global Androgen Antagonist Revenue by Companies
3.4 Top 3 and Top 5 Androgen Antagonist Companies in Global Market, by Revenue in 2024
3.5 Global Companies Androgen Antagonist Product Type
3.6 Tier 1, Tier 2, and Tier 3 Androgen Antagonist Players in Global Market
3.6.1 List of Global Tier 1 Androgen Antagonist Companies
3.6.2 List of Global Tier 2 and Tier 3 Androgen Antagonist Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Androgen Antagonist Market Size Markets, 2024 & 2032
4.1.2 Steroidal Androgen Antagonist
4.1.3 Nonsteroidal Androgen Antagonist
4.2 Segmentation by Type - Global Androgen Antagonist Revenue & Forecasts
4.2.1 Segmentation by Type - Global Androgen Antagonist Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Androgen Antagonist Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Androgen Antagonist Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Androgen Antagonist Market Size, 2024 & 2032
5.1.2 Prostate Cancer
5.1.3 Benign Prostatic Hyperplasia
5.1.4 Polycystic Ovary Syndrome (POCS)
5.1.5 Others
5.2 Segmentation by Application - Global Androgen Antagonist Revenue & Forecasts
5.2.1 Segmentation by Application - Global Androgen Antagonist Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Androgen Antagonist Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Androgen Antagonist Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Androgen Antagonist Market Size, 2024 & 2032
6.2 By Region - Global Androgen Antagonist Revenue & Forecasts
6.2.1 By Region - Global Androgen Antagonist Revenue, 2020-2025
6.2.2 By Region - Global Androgen Antagonist Revenue, 2026-2032
6.2.3 By Region - Global Androgen Antagonist Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Androgen Antagonist Revenue, 2020-2032
6.3.2 United States Androgen Antagonist Market Size, 2020-2032
6.3.3 Canada Androgen Antagonist Market Size, 2020-2032
6.3.4 Mexico Androgen Antagonist Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Androgen Antagonist Revenue, 2020-2032
6.4.2 Germany Androgen Antagonist Market Size, 2020-2032
6.4.3 France Androgen Antagonist Market Size, 2020-2032
6.4.4 U.K. Androgen Antagonist Market Size, 2020-2032
6.4.5 Italy Androgen Antagonist Market Size, 2020-2032
6.4.6 Russia Androgen Antagonist Market Size, 2020-2032
6.4.7 Nordic Countries Androgen Antagonist Market Size, 2020-2032
6.4.8 Benelux Androgen Antagonist Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Androgen Antagonist Revenue, 2020-2032
6.5.2 China Androgen Antagonist Market Size, 2020-2032
6.5.3 Japan Androgen Antagonist Market Size, 2020-2032
6.5.4 South Korea Androgen Antagonist Market Size, 2020-2032
6.5.5 Southeast Asia Androgen Antagonist Market Size, 2020-2032
6.5.6 India Androgen Antagonist Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Androgen Antagonist Revenue, 2020-2032
6.6.2 Brazil Androgen Antagonist Market Size, 2020-2032
6.6.3 Argentina Androgen Antagonist Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Androgen Antagonist Revenue, 2020-2032
6.7.2 Turkey Androgen Antagonist Market Size, 2020-2032
6.7.3 Israel Androgen Antagonist Market Size, 2020-2032
6.7.4 Saudi Arabia Androgen Antagonist Market Size, 2020-2032
6.7.5 UAE Androgen Antagonist Market Size, 2020-2032
7 Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Androgen Antagonist Major Product Offerings
7.1.4 Pfizer Androgen Antagonist Revenue in Global Market (2020-2025)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Androgen Antagonist Major Product Offerings
7.2.4 Johnson & Johnson Androgen Antagonist Revenue in Global Market (2020-2025)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Androgen Antagonist Major Product Offerings
7.3.4 AstraZeneca Androgen Antagonist Revenue in Global Market (2020-2025)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Astellas
7.4.1 Astellas Corporate Summary
7.4.2 Astellas Business Overview
7.4.3 Astellas Androgen Antagonist Major Product Offerings
7.4.4 Astellas Androgen Antagonist Revenue in Global Market (2020-2025)
7.4.5 Astellas Key News & Latest Developments
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Androgen Antagonist Major Product Offerings
7.5.4 Merck Androgen Antagonist Revenue in Global Market (2020-2025)
7.5.5 Merck Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Androgen Antagonist Major Product Offerings
7.6.4 Sanofi Androgen Antagonist Revenue in Global Market (2020-2025)
7.6.5 Sanofi Key News & Latest Developments
7.7 Orion Corporation
7.7.1 Orion Corporation Corporate Summary
7.7.2 Orion Corporation Business Overview
7.7.3 Orion Corporation Androgen Antagonist Major Product Offerings
7.7.4 Orion Corporation Androgen Antagonist Revenue in Global Market (2020-2025)
7.7.5 Orion Corporation Key News & Latest Developments
7.8 Hengrui
7.8.1 Hengrui Corporate Summary
7.8.2 Hengrui Business Overview
7.8.3 Hengrui Androgen Antagonist Major Product Offerings
7.8.4 Hengrui Androgen Antagonist Revenue in Global Market (2020-2025)
7.8.5 Hengrui Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Androgen Antagonist Major Product Offerings
7.9.4 Bayer Androgen Antagonist Revenue in Global Market (2020-2025)
7.9.5 Bayer Key News & Latest Developments
7.10 Schering-Plough
7.10.1 Schering-Plough Corporate Summary
7.10.2 Schering-Plough Business Overview
7.10.3 Schering-Plough Androgen Antagonist Major Product Offerings
7.10.4 Schering-Plough Androgen Antagonist Revenue in Global Market (2020-2025)
7.10.5 Schering-Plough Key News & Latest Developments
7.11 Hinova Pharma
7.11.1 Hinova Pharma Corporate Summary
7.11.2 Hinova Pharma Business Overview
7.11.3 Hinova Pharma Androgen Antagonist Major Product Offerings
7.11.4 Hinova Pharma Androgen Antagonist Revenue in Global Market (2020-2025)
7.11.5 Hinova Pharma Key News & Latest Developments
7.12 Jiangsu Hengrui Pharmaceuticals
7.12.1 Jiangsu Hengrui Pharmaceuticals Corporate Summary
7.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview
7.12.3 Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Major Product Offerings
7.12.4 Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Revenue in Global Market (2020-2025)
7.12.5 Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Androgen Antagonist Market Opportunities & Trends in Global Market
Table 2. Androgen Antagonist Market Drivers in Global Market
Table 3. Androgen Antagonist Market Restraints in Global Market
Table 4. Key Players of Androgen Antagonist in Global Market
Table 5. Top Androgen Antagonist Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Androgen Antagonist Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Androgen Antagonist Revenue Share by Companies, 2020-2025
Table 8. Global Companies Androgen Antagonist Product Type
Table 9. List of Global Tier 1 Androgen Antagonist Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Androgen Antagonist Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Androgen Antagonist Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Androgen Antagonist Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Androgen Antagonist Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Androgen Antagonist Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Androgen Antagonist Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Androgen Antagonist Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Androgen Antagonist Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Androgen Antagonist Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Androgen Antagonist Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Androgen Antagonist Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Androgen Antagonist Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Androgen Antagonist Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Androgen Antagonist Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Androgen Antagonist Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Androgen Antagonist Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Androgen Antagonist Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Androgen Antagonist Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Androgen Antagonist Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Androgen Antagonist Revenue, (US$, Mn), 2026-2032
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Androgen Antagonist Product Offerings
Table 32. Pfizer Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson & Johnson Corporate Summary
Table 35. Johnson & Johnson Androgen Antagonist Product Offerings
Table 36. Johnson & Johnson Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. AstraZeneca Corporate Summary
Table 39. AstraZeneca Androgen Antagonist Product Offerings
Table 40. AstraZeneca Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Astellas Corporate Summary
Table 43. Astellas Androgen Antagonist Product Offerings
Table 44. Astellas Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 45. Astellas Key News & Latest Developments
Table 46. Merck Corporate Summary
Table 47. Merck Androgen Antagonist Product Offerings
Table 48. Merck Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 49. Merck Key News & Latest Developments
Table 50. Sanofi Corporate Summary
Table 51. Sanofi Androgen Antagonist Product Offerings
Table 52. Sanofi Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 53. Sanofi Key News & Latest Developments
Table 54. Orion Corporation Corporate Summary
Table 55. Orion Corporation Androgen Antagonist Product Offerings
Table 56. Orion Corporation Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 57. Orion Corporation Key News & Latest Developments
Table 58. Hengrui Corporate Summary
Table 59. Hengrui Androgen Antagonist Product Offerings
Table 60. Hengrui Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 61. Hengrui Key News & Latest Developments
Table 62. Bayer Corporate Summary
Table 63. Bayer Androgen Antagonist Product Offerings
Table 64. Bayer Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 65. Bayer Key News & Latest Developments
Table 66. Schering-Plough Corporate Summary
Table 67. Schering-Plough Androgen Antagonist Product Offerings
Table 68. Schering-Plough Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 69. Schering-Plough Key News & Latest Developments
Table 70. Hinova Pharma Corporate Summary
Table 71. Hinova Pharma Androgen Antagonist Product Offerings
Table 72. Hinova Pharma Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 73. Hinova Pharma Key News & Latest Developments
Table 74. Jiangsu Hengrui Pharmaceuticals Corporate Summary
Table 75. Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Product Offerings
Table 76. Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Revenue (US$, Mn) & (2020-2025)
Table 77. Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Androgen Antagonist Product Picture
Figure 2. Androgen Antagonist Segment by Type in 2024
Figure 3. Androgen Antagonist Segment by Application in 2024
Figure 4. Global Androgen Antagonist Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Androgen Antagonist Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Androgen Antagonist Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Androgen Antagonist Revenue in 2024
Figure 9. Segmentation by Type � Global Androgen Antagonist Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Androgen Antagonist Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Androgen Antagonist Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Androgen Antagonist Revenue Market Share, 2020-2032
Figure 13. By Region - Global Androgen Antagonist Revenue Market Share, 2020-2032
Figure 14. By Country - North America Androgen Antagonist Revenue Market Share, 2020-2032
Figure 15. United States Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Androgen Antagonist Revenue Market Share, 2020-2032
Figure 19. Germany Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 20. France Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Androgen Antagonist Revenue Market Share, 2020-2032
Figure 27. China Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 31. India Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Androgen Antagonist Revenue Market Share, 2020-2032
Figure 33. Brazil Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Androgen Antagonist Revenue Market Share, 2020-2032
Figure 36. Turkey Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Androgen Antagonist Revenue, (US$, Mn), 2020-2032
Figure 40. Pfizer Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Johnson & Johnson Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. AstraZeneca Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Astellas Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Merck Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Sanofi Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Orion Corporation Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Hengrui Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Bayer Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Schering-Plough Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Hinova Pharma Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
